Convenio Suministros Medicamentos Sistema Nervioso
ADQUIRIR CONVENIO SUMINISTRO DE MEDICAMENTOS SISTEMA NERVIOSO POR UN PERIODO DE 24 MESES
15 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 4429-1422-SE18 | 29-08-2018 | Ethon Pharmaceuticals Ltda. | $121.023 |
| 4429-1279-SE18 | 03-08-2018 | Recben Xenerics Farmaceutica Limitada | $981.750 |
| 4429-1280-SE18 | 03-08-2018 | Ethon Pharmaceuticals Ltda. | $161.840 |
| 4429-1254-SE18 | 02-08-2018 | Winpharm SpA | $2.070.600 |
| 4429-1182-SE18 | 26-07-2018 | Opko Chile S.A. | $1.725.500 |
| 4429-1060-SE18 | 10-07-2018 | Ethon Pharmaceuticals Ltda. | $1.178.100 |
| 4429-1061-SE18 | 10-07-2018 | Recben Xenerics Farmaceutica Limitada | $1.666.000 |
| 4429-757-SE18 | 31-05-2018 | Winpharm SpA | $222.530 |
| 4429-759-SE18 | 31-05-2018 | Novartis Chile S.A. | $535.500 |
| 4429-758-SE18 | 31-05-2018 | Ethon Pharmaceuticals Ltda. | $467.670 |
| 4429-736-SE18 | 24-05-2018 | Ethon Pharmaceuticals Ltda. | $18.826 |
| 4429-677-SE18 | 15-05-2018 | Winpharm SpA | $361.760 |
| 4429-666-SE18 | 11-05-2018 | Ethon Pharmaceuticals Ltda. | $121.380 |
| 4429-609-SE18 | 02-05-2018 | Winpharm SpA | $583.100 |
| 4429-613-SE18 | 02-05-2018 | Ethon Pharmaceuticals Ltda. | $80.682 |
| 4429-611-SE18 | 02-05-2018 | Recben Xenerics Farmaceutica Limitada | $2.082.500 |
| 4429-520-SE18 | 13-04-2018 | Novartis Chile S.A. | $3.046.400 |
| 4429-456-SE18 | 28-03-2018 | Recben Xenerics Farmaceutica Limitada | $464.100 |
| 4429-307-SE18 | 23-02-2018 | Novartis Chile S.A. | $214.200 |
| 4429-285-SE18 | 20-02-2018 | Winpharm SpA | $249.900 |
| 4429-261-SE18 | 15-02-2018 | Recben Xenerics Farmaceutica Limitada | $2.856.000 |
| 4429-153-SE18 | 31-01-2018 | Recben Xenerics Farmaceutica Limitada | $464.100 |
| 4429-154-SE18 | 31-01-2018 | Novartis Chile S.A. | $107.100 |
| 4429-41-SE18 | 09-01-2018 | Recben Xenerics Farmaceutica Limitada | $285.600 |
| 4429-40-SE18 | 09-01-2018 | Ethon Pharmaceuticals Ltda. | $1.178.100 |
| 4429-1995-SE17 | 28-12-2017 | Recben Xenerics Farmaceutica Limitada | $1.309.000 |
| 4429-1986-SE17 | 22-12-2017 | Ethon Pharmaceuticals Ltda. | $5.212.200 |
| 4429-1895-SE17 | 07-12-2017 | Ethon Pharmaceuticals Ltda. | $201.705 |
| 4429-1893-SE17 | 07-12-2017 | Winpharm SpA | $1.428.000 |
| 4429-1874-SE17 | 07-12-2017 | Ethon Pharmaceuticals Ltda. | $377.587 |
| 4429-1853-SE17 | 06-12-2017 | Recben Xenerics Farmaceutica Limitada | $892.500 |
| 4429-1563-SE17 | 16-10-2017 | Novofarma Service S.A. | $471.240 |
| 4429-1562-SE17 | 16-10-2017 | Winpharm SpA | $987.700 |
| 4429-1500-SE17 | 11-10-2017 | Ethon Pharmaceuticals Ltda. | $1.165.010 |
| 4429-1474-SE17 | 04-10-2017 | Recben Xenerics Farmaceutica Limitada | $999.600 |
| 4429-1471-SE17 | 04-10-2017 | Novartis Chile S.A. | $107.100 |
| 4429-1475-SE17 | 04-10-2017 | Novofarma Service S.A. | $130.900 |
| 4429-1360-SE17 | 12-09-2017 | Winpharm SpA | $249.900 |
| 4429-1359-SE17 | 12-09-2017 | Recben Xenerics Farmaceutica Limitada | $952.000 |
| 4429-1241-SE17 | 21-08-2017 | Novartis Chile S.A. | $1.447.040 |
| 4429-1239-SE17 | 21-08-2017 | Ethon Pharmaceuticals Ltda. | $956.879 |
| 4429-1242-SE17 | 21-08-2017 | Winpharm SpA | $678.300 |
| 4429-1243-SE17 | 21-08-2017 | Opko Chile S.A. | $1.725.500 |
| 4429-1244-SE17 | 21-08-2017 | Novofarma Service S.A. | $392.700 |
| 4429-1133-SE17 | 07-08-2017 | Winpharm SpA | $1.178.100 |
| 4429-1106-SE17 | 01-08-2017 | Recben Xenerics Farmaceutica Limitada | $1.428.000 |
| 4429-928-SE17 | 30-06-2017 | Ethon Pharmaceuticals Ltda. | $1.635.060 |
| 4429-777-SE17 | 12-06-2017 | Novartis Chile S.A. | $64.260 |
| 4429-737-SE17 | 06-06-2017 | Winpharm SpA | $249.900 |
| 4429-742-SE17 | 06-06-2017 | Ethon Pharmaceuticals Ltda. | $58.310 |
| 4429-743-SE17 | 06-06-2017 | Novartis Chile S.A. | $2.475.200 |
| 4429-671-SE17 | 25-05-2017 | Ethon Pharmaceuticals Ltda. | $337.770 |
| 4429-682-SE17 | 25-05-2017 | Opko Chile S.A. | $1.725.500 |
| 4429-664-SE17 | 25-05-2017 | Winpharm SpA | $1.428.000 |
| 4429-615-SE17 | 19-05-2017 | Recben Xenerics Farmaceutica Limitada | $199.920 |
| 4429-570-SE17 | 17-05-2017 | Winpharm SpA | $667.590 |
| 4429-576-SE17 | 17-05-2017 | Recben Xenerics Farmaceutica Limitada | $3.022.600 |
| 4429-567-SE17 | 17-05-2017 | Ethon Pharmaceuticals Ltda. | $121.023 |
| 4429-476-SE17 | 02-05-2017 | Ethon Pharmaceuticals Ltda. | $710.430 |
| 4429-475-SE17 | 02-05-2017 | Recben Xenerics Farmaceutica Limitada | $1.047.200 |
| 4429-474-SE17 | 02-05-2017 | Novofarma Service S.A. | $209.440 |
| 4429-417-SE17 | 07-04-2017 | Ethon Pharmaceuticals Ltda. | $18.826 |
| 4429-406-SE17 | 07-04-2017 | Novartis Chile S.A. | $1.904.000 |
| 4429-408-SE17 | 07-04-2017 | Winpharm SpA | $1.071.000 |
| 4429-414-SE17 | 07-04-2017 | Novofarma Service S.A. | $589.050 |
| 4429-386-SE17 | 03-04-2017 | Ethon Pharmaceuticals Ltda. | $991.270 |
| 4429-387-SE17 | 03-04-2017 | Opko Chile S.A. | $1.725.500 |
| 4429-351-SE17 | 27-03-2017 | Ethon Pharmaceuticals Ltda. | $1.042.440 |
| 4429-352-SE17 | 27-03-2017 | Winpharm SpA | $1.171.555 |
| 4429-323-SE17 | 21-03-2017 | Recben Xenerics Farmaceutica Limitada | $2.222.920 |
| 4429-324-SE17 | 21-03-2017 | Ethon Pharmaceuticals Ltda. | $40.460 |
| 4429-322-SE17 | 21-03-2017 | Novofarma Service S.A. | $182.998 |
| 4429-197-SE17 | 23-02-2017 | Recben Xenerics Farmaceutica Limitada | $981.750 |
| 4429-199-SE17 | 23-02-2017 | Novartis Chile S.A. | $1.904.000 |
| 4429-200-SE17 | 23-02-2017 | Winpharm SpA | $595.000 |
| 4429-154-SE17 | 14-02-2017 | Recben Xenerics Farmaceutica Limitada | $428.400 |
| 4429-92-SE17 | 26-01-2017 | Recben Xenerics Farmaceutica Limitada | $228.480 |
| 4429-87-SE17 | 18-01-2017 | Ethon Pharmaceuticals Ltda. | $121.380 |
| 4429-78-SE17 | 17-01-2017 | Recben Xenerics Farmaceutica Limitada | $1.428.000 |
| 4429-81-SE17 | 17-01-2017 | Ethon Pharmaceuticals Ltda. | $1.309.000 |
| 4429-76-SE17 | 17-01-2017 | Winpharm SpA | $615.825 |
| 4429-59-SE17 | 12-01-2017 | Recben Xenerics Farmaceutica Limitada | $309.400 |
| 4429-56-SE17 | 10-01-2017 | Opko Chile S.A. | $862.750 |
| 4429-1668-SE16 | 26-12-2016 | Ethon Pharmaceuticals Ltda. | $353.430 |
| 4429-1653-SE16 | 22-12-2016 | Recben Xenerics Farmaceutica Limitada | $785.400 |
| 4429-1656-SE16 | 22-12-2016 | Novofarma Service S.A. | $392.700 |
| 4429-1651-SE16 | 22-12-2016 | Winpharm SpA | $589.050 |
| 4429-1552-SE16 | 01-12-2016 | Recben Xenerics Farmaceutica Limitada | $171.360 |
| 4429-1553-SE16 | 01-12-2016 | Novofarma Service S.A. | $130.900 |
| 4429-982-SE16 | 05-08-2016 | Ethon Pharmaceuticals Ltda. | $31.531.181 |
| 4429-980-SE16 | 05-08-2016 | Opko Chile S.A. | $11.595.360 |
| 4429-979-SE16 | 05-08-2016 | Novofarma Service S.A. | $5.183.640 |
| 4429-983-SE16 | 05-08-2016 | Winpharm SpA | $64.000.104 |
| 4429-984-SE16 | 05-08-2016 | Recben Xenerics Farmaceutica Limitada | $45.210.480 |
| 4429-981-SE16 | 05-08-2016 | Novartis Chile S.A. | $14.822.640 |
Fuente original:ficha mercadopublico.cl
